These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death. Zhu PJ; Hobson JP; Southall N; Qiu C; Thomas CJ; Lu J; Inglese J; Zheng W; Leppla SH; Bugge TH; Austin CP; Liu S Bioorg Med Chem; 2009 Jul; 17(14):5139-45. PubMed ID: 19540764 [TBL] [Abstract][Full Text] [Related]
9. Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine. Komiyama T; Swanson JA; Fuller RS Antimicrob Agents Chemother; 2005 Sep; 49(9):3875-82. PubMed ID: 16127065 [TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization. Wein AN; Williams BN; Liu S; Ermolinsky B; Provenzano D; Abagyan R; Orry A; Leppla SH; Peredelchuk M J Med Chem; 2012 Sep; 55(18):7998-8006. PubMed ID: 22954387 [TBL] [Abstract][Full Text] [Related]
11. Identification of a lead small-molecule inhibitor of anthrax lethal toxin by using fluorescence-based high-throughput screening. Wei D; Bu Z; Yu A; Li F BMB Rep; 2011 Dec; 44(12):811-5. PubMed ID: 22189685 [TBL] [Abstract][Full Text] [Related]
12. Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo. Pini A; Runci Y; Falciani C; Lelli B; Brunetti J; Pileri S; Fabbrini M; Lozzi L; Ricci C; Bernini A; Tonello F; Dal Molin F; Neri P; Niccolai N; Bracci L Biochem J; 2006 Apr; 395(1):157-63. PubMed ID: 16398644 [TBL] [Abstract][Full Text] [Related]
13. Identification of Therapeutically Active Molecules against Anthrax through Structure and Ligand based Drug Design. Nandi S; Saxena M; Saxena AK Curr Top Med Chem; 2018; 18(27):2294-2312. PubMed ID: 30582475 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of anthrax lethal factor microinjected into macrophage cells through Sendai virus envelopes. Swain PK; Sarkar NK; Sharma M; Goel S; Singh RP; Singh Y Indian J Biochem Biophys; 1997; 34(1-2):186-91. PubMed ID: 9343949 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody. Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894 [TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of anthrax edema factor. Jiao GS; Kim S; Moayeri M; Thai A; Cregar-Hernandez L; McKasson L; O'Malley S; Leppla SH; Johnson AT Bioorg Med Chem Lett; 2018 Jan; 28(2):134-139. PubMed ID: 29198864 [TBL] [Abstract][Full Text] [Related]
18. [Expression, purification and characterization of the recombinant anthrax protective antigen]. Xu JJ; Dong DY; Song XH; Ge M; Li GL; Fu L; Zhuang HL; Chen W Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):652-5. PubMed ID: 15973984 [TBL] [Abstract][Full Text] [Related]
19. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors. Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836 [TBL] [Abstract][Full Text] [Related]
20. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]